Cargando…

New oral anticoagulants: discussion on monitoring and adherence should start now!

New oral anticoagulants (NOACs) have been introduced to improve anticoagulant therapy worldwide, but safe implementation may require additional measures. First, optimization of dose adjustment based on therapeutic levels of the drug may be more appropriate than fixed dose therapy. The development an...

Descripción completa

Detalles Bibliográficos
Autor principal:	ten Cate, Hugo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716685/ https://www.ncbi.nlm.nih.gov/pubmed/23809888 http://dx.doi.org/10.1186/1477-9560-11-8

Ejemplares similares

When to withhold oral anticoagulation in atrial fibrillation – an overview of frequent clinical discussion topics
por: Seelig, Jaap, et al.
Publicado: (2019)

Welcome new guidelines: Now the hard work starts!
por: Bush, Andrew
Publicado: (2019)

Should Now Receive Consideration
Publicado: (1897)

Japan should initiate the discussion on voluntary assisted dying legislation now
por: Asai, Atsushi, et al.
Publicado: (2023)

Target-Specific Oral Anticoagulants—New Approaches in the Field of Oral Anticoagulation
por: Mani, Helen, et al.
Publicado: (2015)

The Revista Brasileira de Hematologia e Hemoterapia now and discussion on the new classification of brazilian journals
por: Ruiz, Milton Artur
Publicado: (2011)

Start Now
por: Kahn, Jessica A.
Publicado: (2020)

Writing the discussion: The analysis should speak for itself
por: Kumar, Ashish
Publicado: (2022)

Neuro Now!: Should Neuroscience be a Department or a Program?
por: Lewis, Richard S.
Publicado: (2006)

Practical guidance on the use of laboratory testing in the management of bleeding in patients receiving direct oral anticoagulants
por: ten Cate, Hugo, et al.
Publicado: (2017)

Organisation of care for patients using direct oral anticoagulants
por: Gulpen, A. J. W., et al.
Publicado: (2020)

After COVID-19 We Will Need a New Research System. We Need To Start Planning Now
por: Bertuzzi, Stefano, et al.
Publicado: (2020)

Hip Surveillance is Important to Children with Cerebral Palsy: Stop Waiting, Start Now
por: Miller, Stacey D., et al.
Publicado: (2019)

Geographic Variations in the Quality of Oral Anticoagulation With Vitamin K Antagonists in the Era of New Anticoagulants
por: Fauchier, Laurent, et al.
Publicado: (2013)

Oral Anticoagulant Therapy: When What Should Not Be Is and What Should Be Is Not
por: Reiffel, James A.
Publicado: (2019)

Aluminum Should Now Be Considered a Primary Etiological Factor in Alzheimer’s Disease
por: Exley, Christopher
Publicado: (2017)

There are considerable drawbacks to oral anticoagulant for monitoring patients at home which should lead family physicians to discuss alternative or enhanced solutions: a cross-sectional study
por: Le Reste, Jean Yves, et al.
Publicado: (2013)

Continuous glucose monitoring in China: Then, now and in the future
por: Jia, Weiping
Publicado: (2016)

Editorial Occupational Biological Monitoring —is now the time?
Publicado: (2020)

The daily practice of direct oral anticoagulant use in patients with atrial fibrillation; an observational cohort study
por: Gulpen, Anouk J. W., et al.
Publicado: (2019)

CMGH: The Revolution Starts Now
por: Turner, Jerrold R., et al.
Publicado: (2015)

Factors related to patient adherence to the use of new oral anticoagulants*
por: Lima, Paula Rocco Gomes, et al.
Publicado: (2021)

Dabigatran and apolipoprotein B
por: ten Cate, Hugo
Publicado: (2016)

Thrombosis management in times of COVID-19 epidemy; a Dutch perspective
por: ten Cate, Hugo
Publicado: (2020)

Surviving Covid-19 with Heparin?
por: ten Cate, Hugo
Publicado: (2021)

Where should we start to improve pediatric heart transplantation outcomes?
por: Song, Jinyoung
Publicado: (2020)

All together now: how and why scientific communities should develop best practice guidelines
por: Lee, Connie M., et al.
Publicado: (2016)

Nursing Development should Now Become a Priority for Health Systems in Europe
por: SKELA-SAVIČ, Brigita
Publicado: (2023)

Functional urology surgery and SARS-CoV-2: How and why surgical activity should be resumed now, adapting to the new reality()
por: Garde-García, H, et al.
Publicado: (2020)

Adherence to oral anticoagulant therapy in secondary stroke prevention – impact of the novel oral anticoagulants
por: Luger, Sebastian, et al.
Publicado: (2015)

Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate
por: Bellamy, L, et al.
Publicado: (2009)

Now for New York. September, 1899
Publicado: (1899)

Should we start vasopressors very early in septic shock?
por: Ospina-Tascón, Gustavo A., et al.
Publicado: (2020)

Editorial for the Special Issue of Monitoring Anticoagulants
por: Amiral, Jean
Publicado: (2022)

COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do?
por: Ikizler, T. Alp
Publicado: (2020)

Use of specific antimicrobials for COVID-19: should we prescribe them now or wait for more evidence?
por: AlAkhras, Abdullah, et al.
Publicado: (2020)

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
por: ten Cate, V., et al.
Publicado: (2016)

Discussion on the New Code
Publicado: (1882)

Suicide prevention: the evidence on safer clinical care is now good and should be adopted internationally
por: Appleby, Louis
Publicado: (2012)

A time of change at Thrombosis Journal
por: ten Cate, Hugo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_q4umufibp6i26ntttqlrpqjusq